𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient

✍ Scribed by Juan Iglesias; Juan Ortega; JesúsAlberto López; Luz Sánchez; Elena Allende; Marino Asensio; Carlos Margarit

Publisher
Springer
Year
2003
Tongue
English
Weight
183 KB
Volume
16
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of mycophenolate mofet
Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients
✍ Marion Margaret Aw; Anita Verma; Mohamed Rela; Nigel Heaton; Giorgina Mieli-Verg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

Mycophenolate mofetil (MMF) has been used to rescue liver allografts with steroid-resistant rejection (SRR). However, the long-term outcome of these patients is not known. This study evaluates the long-term outcome of MMF rescue therapy for SRR in pediatric liver allograft recipients. Twenty-six chi

Outcomes of acute rejection after interf
Outcomes of acute rejection after interferon therapy in liver transplant recipients
✍ Sammy Saab; Denise Kalmaz; Nupoor A. Gajjar; Jonathan Hiatt; Francisco Durazo; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Interferon alfa has been increasingly used against recurrent hepatitis C (HCV) disease in post-liver transplant (LT) recipients. A serious potential adverse effect is acute rejection. We reviewed our experience using interferonbased therapy (interferon or pegylated interferon with or without ribavir